The pharmacokinetics, antihistamine and concentration‐effect relationship of ebastine in healthy subjects.

British Journal of Clinical Pharmacology

Volumn 26, Issue 5, 1988, Pages 497-502

  Vincent, J ^a   Liminana, R ^a   Meredith, PA ^a   Reid, JL ^a  

^a STOBHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CAREBASTINE; EBASTINE; HISTAMINE; PLACEBO;

ADULT; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG METABOLISM; HUMAN; HUMAN EXPERIMENT; INTRADERMAL DRUG ADMINISTRATION; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PRIORITY JOURNAL; URTICARIA;

ADULT; BUTYROPHENONES; COMPARATIVE STUDY; DOSE-RESPONSE RELATIONSHIP, DRUG; HISTAMINE H1 ANTAGONISTS; HUMAN; HYPERSENSITIVITY, IMMEDIATE; MALE; PIPERIDINES; TIME FACTORS;

EID: 0024203291     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.1988.tb05288.x     Document Type: Article

References (18)

1. The quantitative comparison of histamine antagonists in man.
2. The effects of astemizole on histamineinduced weal and flare
3. Relationship between antihistamine activity and plasma level of diphenhydramine.
4. Correlation between plasma diphenhydramine level and sedative and antihistamine effects.
5. Influence of liver disease and environmental factors on hepatic monoxygenase activity
6. Pharmacodynamics and pharmacokinetics of BW 825C: a new antihistamine.
7. Disposition of cyproheptacline in rats, mice and humans and identification of a stable epoxidemetabolite.
8. Inhibitory activity of terfanacline on histamine‐induced skin wheals in man.
9. 1‐receptor antagonists.
10. 1‐histamine receptor antagonists, astemizole and terfanacline.
11. 1‐receptor antagonists, (the antihistamines).
12. A comparison of triprolicline and clemastine on histamine antagonism and performance tests in man: implications for the mechanism of druginduced drowsiness.
13. Human metabolism of cyproheptacline.
14. Circadian reactivity rhythms of human skin to histamine or allergen and the adrenal circle.
15. Astemizole: a review of its pharmacodynamic properties and therapeutic efficacy.
16. Ebastine, a new non‐sedative antihistamine.
17. Ebastine: the effect of a new antihistamine on psychomotor performance and autonomic responses in healthy subjects.
18. Sedation and antihistaminics: